Mixed neuroendocrine-non-neuroendocrine neoplasm with squamous cell carcinoma covered by tubulovillous adenoma in the rectum.

Clin J Gastroenterol

Department of Surgery, School of Medicine, Fujita Health University, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.

Published: August 2021

AI Article Synopsis

  • A rare form of neuroendocrine carcinoma (NEC) called mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) was reported in a case of a 73-year-old man with an upper rectal tumor.
  • The tumor was found to contain large-cell NEC, squamous cell carcinoma (SCC), well-differentiated adenocarcinoma, and was covered by tubulovillous adenoma, complicating diagnosis and treatment.
  • The patient underwent surgery but died 73 days later from liver metastases, highlighting the need for further research and appropriate management strategies for these aggressive tumors.

Article Abstract

A variety of histologies is often mixed in neuroendocrine carcinoma (NEC) called mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN). However, tumors consisting of both large-cell NEC and squamous cell carcinoma (SCC) are rare. NEC of the large intestine is aggressive; however, an ideal treatment strategy has not been established. In this study, we have reported a case of rectal MiNEN containing large-cell NEC and SCC that was covered by tubulovillous adenoma. A 73-year-old man was referred to our hospital for the treatment of an upper rectal tumor. The results of preoperative biopsy indicated tubulovillous adenoma, whereas computed tomography revealed multiple liver tumors and swollen lymph nodes around the rectum. Laparotomy was performed because of severe dyschezia caused by rectal stenosis. Hartmann's operation was performed because of peritoneal metastases. Histopathological examination of the rectal tumor revealed MiNEN containing large-cell NEC, SCC, well-differentiated adenocarcinoma, and tubulovillous adenoma covering the surface of the tumor. The patient died 73 days after surgery due to liver metastases. It is important to consider NEC in the differential diagnosis and tissue sampling should be performed to ensure appropriate management when pathological findings and clinical diagnosis do not match. More research is required to determine the ideal treatment for these rare and aggressive tumors.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12328-021-01420-8DOI Listing

Publication Analysis

Top Keywords

tubulovillous adenoma
16
large-cell nec
12
mixed neuroendocrine-non-neuroendocrine
8
neuroendocrine-non-neuroendocrine neoplasm
8
squamous cell
8
cell carcinoma
8
covered tubulovillous
8
ideal treatment
8
minen large-cell
8
nec scc
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!